Financial results - HELIOS PHARM SRL

Financial Summary - Helios Pharm Srl
Unique identification code: 23195033
Registration number: J21/72/2008
Nace: 4773
Sales - Ron
848.505
Net Profit - Ron
2.325
Employees
12
Open Account
Company Helios Pharm Srl with Fiscal Code 23195033 recorded a turnover of 2024 of 848.505, with a net profit of 2.325 and having an average number of employees of 12. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Helios Pharm Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 734.122 786.907 869.057 1.020.210 750.436 822.016 775.719 783.674 750.697 848.505
Total Income - EUR 734.620 787.186 869.528 1.022.953 750.463 822.069 775.800 804.014 750.747 849.611
Total Expenses - EUR 591.271 888.048 730.780 873.176 698.982 758.519 724.948 751.008 737.791 846.644
Gross Profit/Loss - EUR 143.348 -100.862 138.748 149.777 51.481 63.549 50.851 53.006 12.956 2.966
Net Profit/Loss - EUR 121.579 -100.862 134.153 136.709 43.037 56.377 43.305 45.069 8.797 2.325
Employees 8 10 12 13 13 11 11 11 11 12
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 13.7%, from 750.697 euro in the year 2023, to 848.505 euro in 2024. The Net Profit decreased by -6.423 euro, from 8.797 euro in 2023, to 2.325 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Helios Pharm Srl

Rating financiar

Financial Rating -
HELIOS PHARM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Helios Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Helios Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Helios Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Helios Pharm Srl - CUI 23195033

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 23.657 106.214 102.710 99.319 97.059 94.510 92.463 78.816 107.477 108.384
Current Assets 477.483 234.701 318.026 423.764 475.125 506.062 468.272 436.531 372.630 388.906
Inventories 182.247 171.979 210.932 229.635 355.847 396.696 375.620 340.322 283.408 302.755
Receivables 272.382 34.337 85.643 108.026 69.980 88.089 80.783 84.111 82.070 71.989
Cash 22.854 28.385 21.450 86.103 49.298 21.277 11.869 12.098 7.151 14.162
Shareholders Funds 341.220 101.166 176.893 313.761 47.685 103.159 143.688 49.052 57.701 59.704
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 160.409 240.914 244.207 209.681 524.824 497.526 417.590 466.294 422.406 437.590
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 388.906 euro in 2024 which includes Inventories of 302.755 euro, Receivables of 71.989 euro and cash availability of 14.162 euro.
The company's Equity was valued at 59.704 euro, while total Liabilities amounted to 437.590 euro. Equity increased by 2.325 euro, from 57.701 euro in 2023, to 59.704 in 2024.

Risk Reports Prices

Reviews - Helios Pharm Srl

Comments - Helios Pharm Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.